{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:34:52Z","timestamp":1787312092965,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100030692","name":"Intramural Research Program, National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA055758"],"award-info":[{"award-number":["K01DA055758"]}],"id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s11606-024-09108-8","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T14:02:57Z","timestamp":1729605777000},"page":"1048-1058","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Toward a Consensus on Strategies to Support Opioid Use Disorder Care Transitions Following Hospitalization: A Modified Delphi Process"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7396-3938","authenticated-orcid":false,"given":"Noa","family":"Krawczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honora","family":"Englander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca D.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Schatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Cerd\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"McNeely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,22]]},"reference":[{"key":"9108_CR1","unstructured":"Centers for Disease Control and Prevention. Provisional Drug Overdose Death Counts. National Center for Health Statistics. April 12, 2024. Accessed April 29, 2024. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm"},{"issue":"110","key":"9108_CR2","doi-asserted-by":"publisher","first-page":"103786","DOI":"10.1016\/j.drugpo.2022.103786","volume":"2022","author":"N Krawczyk","year":"2010","unstructured":"Krawczyk N, Rivera BD, Jent V, Keyes KM, Jones CM, Cerd\u00e1 M. Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019\u201d. Int J Drug Policy. 2022;110:103786. https:\/\/doi.org\/10.1016\/j.drugpo.2022.103786","journal-title":"Int J Drug Policy."},{"issue":"2","key":"9108_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1176\/appi.ajp.2019.19060612","volume":"177","author":"AR Williams","year":"2020","unstructured":"Williams AR, Samples H, Crystal S, Olfson M. Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use Disorder. Am J Psychiatry. 2020;177(2):117-124. https:\/\/doi.org\/10.1176\/appi.ajp.2019.19060612","journal-title":"Am J Psychiatry."},{"issue":"16","key":"9108_CR4","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1001\/jama.2015.3474","volume":"313","author":"G D\u2019Onofrio","year":"2015","unstructured":"D\u2019Onofrio G, O\u2019Connor PG, Pantalon MV, et al. Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial. JAMA. 2015;313(16):1636-1644. https:\/\/doi.org\/10.1001\/jama.2015.3474","journal-title":"JAMA."},{"issue":"8","key":"9108_CR5","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1001\/jamainternmed.2014.2556","volume":"174","author":"JM Liebschutz","year":"2014","unstructured":"Liebschutz JM, Crooks D, Herman D, et al. Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial. JAMA Intern Med. 2014;174(8):1369-1376. https:\/\/doi.org\/10.1001\/jamainternmed.2014.2556","journal-title":"JAMA Intern Med."},{"issue":"1","key":"9108_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/ajad.12161","volume":"24","author":"J Suzuki","year":"2015","unstructured":"Suzuki J, DeVido J, Kalra I, et al. Initiating buprenorphine treatment for hospitalized patients with opioid dependence: A case series. Am J Addict. 2015;24(1):10-14. https:\/\/doi.org\/10.1111\/ajad.12161","journal-title":"Am J Addict."},{"key":"9108_CR7","doi-asserted-by":"publisher","unstructured":"McNeely J, Wang SS, Rostam Abadi Y, et al. Addiction Consultation Services for Opioid Use Disorder Treatment Initiation and Engagement: A Randomized Clinical Trial. JAMA Intern Med. Published online July 29, 2024:e243422. https:\/\/doi.org\/10.1001\/jamainternmed.2024.3422","DOI":"10.1001\/jamainternmed.2024.3422"},{"issue":"1","key":"9108_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13722-018-0117-1","volume":"13","author":"K Hawk","year":"2018","unstructured":"Hawk K, D\u2019Onofrio G. Emergency department screening and interventions for substance use disorders. Addict Sci Clin Pract. 2018;13(1):18. https:\/\/doi.org\/10.1186\/s13722-018-0117-1","journal-title":"Addict Sci Clin Pract."},{"issue":"3","key":"9108_CR9","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1097\/ADM.0000000000001092","volume":"17","author":"KR Noam","year":"2023","unstructured":"Noam KR, Schmutte TJ, Pirard S, Bourdon C, Langless D, Plant R. Associations Between Inpatient Induction on Medications for Opioid Use Disorder and Postdischarge Medications for Opioid Use Disorder Adherence, Overdose, and Service Use. J Addict Med. 2023;17(3):e199. https:\/\/doi.org\/10.1097\/ADM.0000000000001092","journal-title":"J Addict Med."},{"issue":"11","key":"9108_CR10","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1007\/s11606-022-07618-x","volume":"37","author":"H Englander","year":"2022","unstructured":"Englander H, Jones A, Krawczyk N, et al. A Taxonomy of Hospital-Based Addiction Care Models: a Scoping Review and Key Informant Interviews. J Gen Intern Med. 2022;37(11):2821-2833. https:\/\/doi.org\/10.1007\/s11606-022-07618-x","journal-title":"J Gen Intern Med."},{"issue":"12","key":"9108_CR11","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1007\/s11606-019-05251-9","volume":"34","author":"H Englander","year":"2019","unstructured":"Englander H, Dobbertin K, Lind BK, et al. Inpatient Addiction Medicine Consultation and Post-Hospital Substance Use Disorder Treatment Engagement: a Propensity-Matched Analysis. J Gen Intern Med. 2019;34(12):2796-2803. https:\/\/doi.org\/10.1007\/s11606-019-05251-9","journal-title":"J Gen Intern Med."},{"key":"9108_CR12","doi-asserted-by":"publisher","first-page":"209377","DOI":"10.1016\/j.josat.2024.209377","volume":"163","author":"I Danovitch","year":"2024","unstructured":"Danovitch I, Korouri S, Kaur H, et al. The addiction consultation service for hospitalized patients with substance use disorder: An integrative review of the evidence. J Subst Use Addict Treat. 2024;163:209377. https:\/\/doi.org\/10.1016\/j.josat.2024.209377","journal-title":"J Subst Use Addict Treat."},{"issue":"10","key":"9108_CR13","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/jhm.13193","volume":"18","author":"SL Calcaterra","year":"2023","unstructured":"Calcaterra SL, Lockhart S, Natvig C, Mikulich S. Barriers to initiate buprenorphine and methadone for opioid use disorder treatment with postdischarge treatment linkage. J Hosp Med. 2023;18(10):896-907. https:\/\/doi.org\/10.1002\/jhm.13193","journal-title":"J Hosp Med."},{"key":"9108_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2017.05.007","volume":"79","author":"P Trowbridge","year":"2017","unstructured":"Trowbridge P, Weinstein ZM, Kerensky T, et al. Addiction consultation services - Linking hospitalized patients to outpatient addiction treatment. J Subst Abuse Treat. 2017;79:1-5. https:\/\/doi.org\/10.1016\/j.jsat.2017.05.007","journal-title":"J Subst Abuse Treat."},{"issue":"1","key":"9108_CR15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/24734306.2020.1869899","volume":"5","author":"A Upadhyaya","year":"2021","unstructured":"Upadhyaya A, Marks LR, Schwarz ES, Liang SY, Durkin MJ, Liss DB. Care cascade for patients with opioid use disorder and serious injection related infections. Toxicol Commun. 2021;5(1):6-10. https:\/\/doi.org\/10.1080\/24734306.2020.1869899","journal-title":"Toxicol Commun."},{"issue":"3","key":"9108_CR16","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jsat.2013.10.004","volume":"46","author":"J Gryczynski","year":"2014","unstructured":"Gryczynski J, Mitchell SG, Jaffe JH, O\u2019Grady KE, Olsen YK, Schwartz RP. Leaving buprenorphine treatment: Patients\u2019 reasons for cessation of care. J Subst Abuse Treat. 2014;46(3):356-361. https:\/\/doi.org\/10.1016\/j.jsat.2013.10.004","journal-title":"J Subst Abuse Treat."},{"issue":"1","key":"9108_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13722-023-00422-w","volume":"18","author":"N Krawczyk","year":"2023","unstructured":"Krawczyk N, Rivera BD, Chang JE, et al. Strategies to support substance use disorder care transitions from acute-care to community-based settings: a scoping review and typology. Addict Sci Clin Pract. 2023;18(1):67. https:\/\/doi.org\/10.1186\/s13722-023-00422-w","journal-title":"Addict Sci Clin Pract."},{"issue":"2","key":"9108_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/ADM.0000000000001250","volume":"18","author":"N Krawczyk","year":"2024","unstructured":"Krawczyk N, Rivera BD, Chang JE, Lindenfeld Z, Franz B. Initiatives to Support the Transition of Patients With Substance Use Disorders From Acute Care to Community-based Services Among a National Sample of Nonprofit Hospitals. J Addict Med. 2024;18(2):115-121. https:\/\/doi.org\/10.1097\/ADM.0000000000001250","journal-title":"J Addict Med."},{"issue":"5","key":"9108_CR19","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s11606-024-08670-5","volume":"39","author":"MA Incze","year":"2024","unstructured":"Incze MA, Kelley AT, James H, et al. Post-hospitalization Care Transition Strategies for Patients with Substance Use Disorders: A Narrative Review and Taxonomy. J Gen Intern Med. 2024;39(5):837-846. https:\/\/doi.org\/10.1007\/s11606-024-08670-5","journal-title":"J Gen Intern Med."},{"issue":"7","key":"9108_CR20","doi-asserted-by":"publisher","first-page":"899","DOI":"10.7326\/M20-5475","volume":"174","author":"J Gryczynski","year":"2021","unstructured":"Gryczynski J, Nordeck CD, Welsh C, Mitchell SG, O\u2019Grady KE, Schwartz RP. Preventing Hospital Readmission for Patients With Comorbid Substance Use Disorder. Ann Intern Med. 2021;174(7):899-909. https:\/\/doi.org\/10.7326\/M20-5475","journal-title":"Ann Intern Med."},{"key":"9108_CR21","unstructured":"Fitch K, Bernstein SJ, Aguilar MD, et al. The RAND\/UCLA Appropriateness Method User\u2019s Manual. RAND Corporation; 2001. Accessed April 29, 2024. https:\/\/www.rand.org\/pubs\/monograph_reports\/MR1269.html"},{"issue":"4","key":"9108_CR22","doi-asserted-by":"publisher","first-page":"e12823","DOI":"10.1111\/mcn.12823","volume":"15","author":"T Thepha","year":"2019","unstructured":"Thepha T, Marais D, Bell J, Muangpin S. Concept mapping to reach consensus on a 6-month exclusive breastfeeding strategy model to improve the rate in Northeast Thailand. Matern Child Nutr. 2019;15(4):e12823. https:\/\/doi.org\/10.1111\/mcn.12823","journal-title":"Matern Child Nutr."},{"key":"9108_CR23","doi-asserted-by":"crossref","unstructured":"Kane M, Trochim WMK. Concept Mapping for Planning and Evaluation. Sage Publications, Inc; 2007:xv, 200.","DOI":"10.4135\/9781412983730"},{"issue":"2","key":"9108_CR24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010","journal-title":"J Biomed Inform."},{"key":"9108_CR25","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208","journal-title":"J Biomed Inform."},{"key":"9108_CR26","doi-asserted-by":"publisher","first-page":"e003","DOI":"10.5334\/ijic.1513","volume":"15","author":"PP Valentijn","year":"2015","unstructured":"Valentijn PP, Boesveld IC, van der Klauw DM, et al. Towards a taxonomy for integrated care: a mixed-methods study. Int J Integr Care. 2015;15:e003.","journal-title":"Int J Integr Care."},{"key":"9108_CR27","unstructured":"StataCorp. Stata Statistical Software: Release 18. Published online 2023."},{"key":"9108_CR28","doi-asserted-by":"publisher","first-page":"209280","DOI":"10.1016\/j.josat.2023.209280","volume":"160","author":"B Franz","year":"2024","unstructured":"Franz B, Cronin CE, Lindenfeld Z, et al. Rural-urban disparities in the availability of hospital-based screening, medications for opioid use disorder, and addiction consult services. J Subst Use Addict Treat. 2024;160:209280. https:\/\/doi.org\/10.1016\/j.josat.2023.209280","journal-title":"J Subst Use Addict Treat."},{"key":"9108_CR29","doi-asserted-by":"publisher","first-page":"108719","DOI":"10.1016\/j.jsat.2022.108719","volume":"138","author":"JE Chang","year":"2022","unstructured":"Chang JE, Franz B, Cronin CE, Lindenfeld Z, Lai AY, Pag\u00e1n JA. Racial\/ethnic disparities in the availability of hospital based opioid use disorder treatment. J Subst Abuse Treat. 2022;138:108719. https:\/\/doi.org\/10.1016\/j.jsat.2022.108719","journal-title":"J Subst Abuse Treat."},{"issue":"8","key":"9108_CR30","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1007\/s11606-020-05815-0","volume":"35","author":"KC Priest","year":"2020","unstructured":"Priest KC, Lovejoy TI, Englander H, Shull S, McCarty D. Opioid Agonist Therapy During Hospitalization Within the Veterans Health Administration: a Pragmatic Retrospective Cohort Analysis. J Gen Intern Med. 2020;35(8):2365-2374. https:\/\/doi.org\/10.1007\/s11606-020-05815-0","journal-title":"J Gen Intern Med."},{"issue":"3","key":"9108_CR31","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.sapharm.2023.12.001","volume":"20","author":"S Nedjat","year":"2024","unstructured":"Nedjat S, Wang Y, Eshtiaghi K, Fleming M. Is there a disparity in medications for opioid use disorder based on race\/ethnicity and gender? A systematic review and meta-analysis. Res Soc Adm Pharm RSAP. 2024;20(3):236-245. https:\/\/doi.org\/10.1016\/j.sapharm.2023.12.001","journal-title":"Res Soc Adm Pharm RSAP."},{"issue":"1","key":"9108_CR32","doi-asserted-by":"publisher","first-page":"2270632","DOI":"10.1080\/17445647.2023.2270632","volume":"19","author":"P Mitchell","year":"2023","unstructured":"Mitchell P, Curtin KM, Magliocca NR. Race, rurality and geographic accessibility to medication for opioid use disorder in the US. J Maps. 2023;19(1):2270632. https:\/\/doi.org\/10.1080\/17445647.2023.2270632","journal-title":"J Maps."},{"issue":"11","key":"9108_CR33","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/acem.14054","volume":"27","author":"J Kaczorowski","year":"2020","unstructured":"Kaczorowski J, Bilodeau J, M Orkin A, Dong K, Daoust R, Kestler A. Emergency Department\u2013initiated Interventions for Patients With Opioid Use Disorder: A Systematic Review. Acad Emerg Med. 2020;27(11):1173-1182. https:\/\/doi.org\/10.1111\/acem.14054","journal-title":"Acad Emerg Med."},{"issue":"6","key":"9108_CR34","doi-asserted-by":"publisher","first-page":"345","DOI":"10.12788\/jhm.3591","volume":"16","author":"N Christian","year":"2021","unstructured":"Christian N, Bottner R, Baysinger A, et al. Hospital Buprenorphine Program for Opioid Use Disorder Is Associated With Increased Inpatient and Outpatient Addiction Treatment. J Hosp Med. 2021;16(6):345-348. https:\/\/doi.org\/10.12788\/jhm.3591","journal-title":"J Hosp Med."},{"issue":"1","key":"9108_CR35","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/08897077.2021.1949663","volume":"43","author":"R French","year":"2022","unstructured":"French R, Aronowitz SV, Brooks Carthon JM, Schmidt HD, Compton P. Interventions for Hospitalized Medical and Surgical Patients with Opioid use Disorder: A Systematic Review. Subst Abuse. 2022;43(1):495-507. https:\/\/doi.org\/10.1080\/08897077.2021.1949663","journal-title":"Subst Abuse."},{"issue":"12","key":"9108_CR36","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1176\/appi.ps.202100627","volume":"73","author":"MA Stimmel","year":"2022","unstructured":"Stimmel MA, Smelson D, Finlay AK. Moving Beyond the Medication or Psychosocial Treatment Dichotomy to Address the Opioid Epidemic. Psychiatr Serv. 2022;73(12):1320-1321. https:\/\/doi.org\/10.1176\/appi.ps.202100627","journal-title":"Psychiatr Serv."},{"issue":"1","key":"9108_CR37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/ADM.0000000000001246","volume":"18","author":"E Skogrand","year":"2024","unstructured":"Skogrand E, Sharpe J, Englander H. Dispensing Methadone at Hospital Discharge: One Hospital\u2019s Approach to Implementing the \u201c72-hour Rule\u201d Change. J Addict Med. 2024;18(1):71-74. https:\/\/doi.org\/10.1097\/ADM.0000000000001246","journal-title":"J Addict Med."},{"key":"9108_CR38","unstructured":"Varshneya, PhD NB, Thakrar, MD A, Hobelmann, MD JG, Dunn, PhD, MBA KE, Huhn, PhD, MBA AS. Evidence of Buprenorphine-precipitated Withdrawal in Persons...\u202f: Journal of Addiction Medicine. Accessed April 29, 2024. https:\/\/journals.lww.com\/journaladdictionmedicine\/abstract\/9000\/Evidence_of_Buprenorphine_precipitated_Withdrawal.98967.aspx\/1000?casa_token=Xf38YT66RrAAAAAA:N_aIyRtnA5l2XtkBcUdfu0yBEEiq3dDhsC-L23h69DGCF0m7CBF42BcWtarXdsVqpSONWsSoxpexZc6DwrztAlDRJTA"},{"issue":"1","key":"9108_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s13181-021-00858-z","volume":"18","author":"SH Kessler","year":"2022","unstructured":"Kessler SH, Schwarz ES, Liss DB. Methadone vs. Buprenorphine for In-Hospital Initiation: Which Is Better for Outpatient Care Retention in Patients with Opioid Use Disorder? J Med Toxicol. 2022;18(1):11-18. https:\/\/doi.org\/10.1007\/s13181-021-00858-z","journal-title":"J Med Toxicol."},{"issue":"1","key":"9108_CR40","doi-asserted-by":"publisher","first-page":"qxad018","DOI":"10.1093\/haschl\/qxad018","volume":"1","author":"N Krawczyk","year":"2023","unstructured":"Krawczyk N, Joudrey PJ, Simon R, Russel DM, Frank D. Recent modifications to the US methadone treatment system are a Band-Aid\u2014not a solution\u2014to the nation\u2019s broken opioid use disorder treatment system. Health Aff Sch. 2023;1(1):qxad018. https:\/\/doi.org\/10.1093\/haschl\/qxad018","journal-title":"Health Aff Sch."},{"issue":"1","key":"9108_CR41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/add.13146","volume":"111","author":"JE Glass","year":"2016","unstructured":"Glass JE, Hamilton AM, Powell BJ, Perron BE, Brown RT, Ilgen MA. Revisiting our review of Screening, Brief Intervention and Referral to Treatment (SBIRT): meta-analytical results still point to no efficacy in increasing the use of substance use disorder services. Addict Abingdon Engl. 2016;111(1):181-183. https:\/\/doi.org\/10.1111\/add.13146","journal-title":"Addict Abingdon Engl."},{"issue":"9","key":"9108_CR42","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1111\/add.12950","volume":"110","author":"JE Glass","year":"2015","unstructured":"Glass JE, Hamilton AM, Powell BJ, Perron BE, Brown RT, Ilgen MA. Specialty substance use disorder services following brief alcohol intervention: a meta-analysis of randomized controlled trials. Addict Abingdon Engl. 2015;110(9):1404-1415. https:\/\/doi.org\/10.1111\/add.12950","journal-title":"Addict Abingdon Engl."},{"key":"9108_CR43","doi-asserted-by":"publisher","unstructured":"Englander H, Thakrar AP, Bagley SM, Rolley T, Dong K, Hyshka E. Caring for Hospitalized Adults With Opioid Use Disorder in the Era of Fentanyl: A Review. JAMA Intern Med. Published online April 29, 2024. https:\/\/doi.org\/10.1001\/jamainternmed.2023.7282","DOI":"10.1001\/jamainternmed.2023.7282"},{"issue":"4","key":"9108_CR44","doi-asserted-by":"publisher","first-page":"e235439","DOI":"10.1001\/jamanetworkopen.2023.5439","volume":"6","author":"G D\u2019Onofrio","year":"2023","unstructured":"D\u2019Onofrio G, Edelman EJ, Hawk KF, et al. Implementation Facilitation to Promote Emergency Department\u2013Initiated Buprenorphine for Opioid Use Disorder. JAMA Netw Open. 2023;6(4):e235439. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.5439","journal-title":"JAMA Netw Open."},{"key":"9108_CR45","unstructured":"Bridge. On Demand. Bridge to Treatment. Accessed April 29, 2024. https:\/\/bridgetotreatment.org\/trainings\/on-demand\/"},{"issue":"8","key":"9108_CR46","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMp2204687","volume":"387","author":"Englander Honora","year":"2022","unstructured":"Englander Honora, Davis Corey S. Hospital Standards of Care for People with Substance Use Disorder. N Engl J Med. 2022;387(8):672-675. https:\/\/doi.org\/10.1056\/NEJMp2204687","journal-title":"N Engl J Med."},{"key":"9108_CR47","doi-asserted-by":"publisher","unstructured":"Englander H. Opioid Use Disorder Medications After Hospitalization-Rethinking Engagement in Care. JAMA Intern Med. Published online July 29, 2024. https:\/\/doi.org\/10.1001\/jamainternmed.2024.3436","DOI":"10.1001\/jamainternmed.2024.3436"},{"key":"9108_CR48","doi-asserted-by":"publisher","unstructured":"Krawczyk N, Rivera BD, Chang JE, et al. Strategies to support substance use disorder care transitions from acute-care to community-based settings: A Scoping review and typology. MedRxiv Prepr Serv Health Sci. Published online June 25, 2023:2023.04.24.23289042. https:\/\/doi.org\/10.1101\/2023.04.24.23289042","DOI":"10.1101\/2023.04.24.23289042"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-024-09108-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-024-09108-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-024-09108-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T18:09:38Z","timestamp":1764266978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-024-09108-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,22]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["9108"],"URL":"https:\/\/doi.org\/10.1007\/s11606-024-09108-8","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,22]]},"assertion":[{"value":"4 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations:"}},{"value":"Noa Krawczyk and Magdalena Cerd\u00e1 provide expert witness testimony in ongoing opioid litigation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest:"}},{"value":"The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer:"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}